Molecular Diagnostics

Molecular Diagnostics

Global Molecular Diagnostics Market to Reach $27 Billion by 2030
The global market for Molecular Diagnostics estimated at US$13.6 Billion in the year 2022, is expected to reach US$27 Billion by 2030, growing at a CAGR of 9% over the period 2022-2030. Molecular Diagnostic Reagents & Kits, one of the segments analyzed in the report, is expected to record 9.5% CAGR and reach US$16 Billion by the end of the analysis period. Growth in the Molecular Diagnostic Instruments segment is estimated at 8.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $5.8 Billion, While China is Forecast to Grow at 10.3% CAGR
The Molecular Diagnostics market in the U.S. is estimated at US$5.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 7.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 84 Featured) -
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Asuragen, Inc.
  • Analytik Jena AG
  • A. Menarini Diagnostics Srl
  • Abaxis, Inc.
  • Agena Bioscience, Inc.
  • Advanced Cell Diagnostics, Inc.
  • AutoGenomics, Inc.
  • Akonni Biosystems, Inc.
  • Berg LLC
  • Agendia, Inc.
  • BioAgilytix Labs
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
Molecular Diagnostics: An Introduction
Types of Molecular Diagnostics Tests
Market Outlook
Major Growth Drivers
Developing Countries Offer Strong Growth Prospects
PCR Technology Leads the MDx Market
Infectious Diseases: The Largest Application Market
Reagents and Kits Dominate the Molecular Diagnostics Market
Competition
Pharmaceutical Firms Carve their Niche in Molecular Diagnostic Market
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Technological Innovations Set to Drive Market Growth
New Product Developments
Digitalization Trends Benefit Growth
Growing Role of Molecular Diagnostics in Personalized Medicine
Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
Companion Diagnostics Drive Personalized Medicine
Biomarkers as Companion Diagnostics
Oncology-Based Molecular Diagnostics Lead Growth
Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
New Applications Hold Promising Potential
Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum
Rising Emphasis on Lab Automation to Augur Well for Market Growth
World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
Nanotechnology for Molecular Diagnostics
Growing Popularity of Chemo-Sensitivity Testing of CTCs
Genetic Disease Testing Offers Bright Prospects
Genetic Testing to Aid in Personalized Medicine
Pharmacogenomics Development Augurs Growth of Genetic Testing Market
Non-Invasive Prenatal Diagnostics - The Way Ahead
Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
Growing Incidence of Infectious Diseases Spurs Opportunities
Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
Rising Incidence of Hospital Acquired Infections Propels Market Growth
Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
Home HIV Testing Emerges as a Lucrative Option
Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
Hepatitis B prevalence Worldwide by Region
HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market
Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing
Molecular based Tests Ingrain Roots in Blood Donor Screening Segment
Rise in Healthcare Expenditure to Drive Growth
World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
Aging Population Drives Molecular Diagnostics Market
Elderly Healthcare Expenditure as a % of GDP
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Software & Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for In-Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Isothermal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Chips & Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 35: World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 36: World 16-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 37: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 38: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 39: World 16-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 42: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 43: World Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Market Analytics
Market Overview
Infectious Disease Testing Contributes to High Growth
Ageing Demographics: Major Driving Factor
US Elderly Population: Expected Growth Rates Over the Years 2005-2025
Increasing Incidence of Chronic Diseases Drives Focus onto Molecular Diagnostics
Rising Incidence of Cancer: A Major Growth Driver
Molecular Diagnostics Tests Gain Share in STD Testing Domain
HPV Testing Market: A Review
Prevalence of HPV in the US by Age
US Personalized Medicine Market to Offer Significant Opportunities
Companion Diagnostics Market in the US
Burgeoning Potential for Genetic Testing
Paradigm Shift amongst Consumers Spurs DTC Genetic Testing Market
TABLE 44: USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: USA Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: USA 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: USA Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: USA 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
CANADA
TABLE 53: Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Canada 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Canada 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Canada 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
JAPAN
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Market Overview
Brief Note on COVID-19 Testing in Japan
Demographics Drive Market Growth
Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
Market Analytics
TABLE 62: Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Japan 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 65: Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Japan 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Japan 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
CHINA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Market Overview
COVID-19 Testing: An Overview
HPV Testing in China
Market Analytics
TABLE 71: China Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: China Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: China 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 74: China Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: China Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: China 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: China Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: China 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
EUROPE
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Market Overview
Aging Population: A Prime Growth Driver
Automated Systems Gain Preeminence
Oncology-based Molecular Diagnostics Holds Immense Potential
Number of New Cancer Cases in Europe: 2012, 2018, and 2025
HPV Testing in Europe: An Overview
Market Analytics
TABLE 80: Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Europe 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Europe 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
FRANCE
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 92: France Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: France Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: France 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 95: France Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: France Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: France 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 98: France Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: France Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: France 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
GERMANY
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 101: Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Germany 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 104: Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: Germany Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Germany 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 107: Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Germany Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Germany 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
ITALY
TABLE 110: Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Italy 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 113: Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Italy Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Italy 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 116: Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Italy Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Italy 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
UNITED KINGDOM
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 119: UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: UK Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: UK 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 122: UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: UK Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: UK 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 125: UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: UK Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: UK 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
SPAIN
TABLE 128: Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Spain Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Spain 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 131: Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Spain Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Spain 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 134: Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Spain Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Spain 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
RUSSIA
TABLE 137: Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Russia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Russia 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 140: Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Russia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Russia 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 143: Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Russia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Russia 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of Europe 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Rest of Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Rest of Europe 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Rest of Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Rest of Europe 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Market Overview
Healthcare Spending in Asia-Pacific: On the Rise
Market Analytics
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
AUSTRALIA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 167: Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Australia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Australia 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 170: Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: Australia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Australia 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 173: Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Australia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Australia 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
INDIA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
Market Overview
Laboratories Pick up on Automation
HPV Testing Market: An Overview
HPV in India: Breakdown of Type-Distribution and HPV Prevalence
Market Analytics
TABLE 176: India Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: India Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: India 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 179: India Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: India Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: India 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 182: India Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: India Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: India 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 185: South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: South Korea Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: South Korea 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 188: South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: South Korea Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: South Korea 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 191: South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: South Korea Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: South Korea 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
LATIN AMERICA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 203: Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Latin America 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 206: Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Latin America 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 209: Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Latin America 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 212: Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Latin America 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 215: Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 216: Argentina Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 217: Argentina 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 218: Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 219: Argentina Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 220: Argentina 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 221: Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 222: Argentina Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 223: Argentina 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
BRAZIL
TABLE 224: Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 225: Brazil Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 226: Brazil 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 227: Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 228: Brazil Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 229: Brazil 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 230: Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 231: Brazil Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 232: Brazil 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
MEXICO
TABLE 233: Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 234: Mexico Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 235: Mexico 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 236: Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 237: Mexico Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 238: Mexico 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 239: Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 240: Mexico Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 241: Mexico 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 243: Rest of Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 244: Rest of Latin America 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 246: Rest of Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 247: Rest of Latin America 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 249: Rest of Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 250: Rest of Latin America 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
MIDDLE EAST
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 251: Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 253: Middle East 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 254: Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 256: Middle East 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 257: Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 258: Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 259: Middle East 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 260: Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 261: Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 262: Middle East 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
IRAN
TABLE 263: Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 264: Iran Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 265: Iran 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 266: Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 267: Iran Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 268: Iran 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 269: Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 270: Iran Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 271: Iran 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
ISRAEL
TABLE 272: Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 273: Israel Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 274: Israel 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 275: Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 276: Israel Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 277: Israel 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 278: Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 279: Israel Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 280: Israel 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 282: Saudi Arabia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 283: Saudi Arabia 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 285: Saudi Arabia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 286: Saudi Arabia 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 288: Saudi Arabia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 289: Saudi Arabia 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 290: UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 291: UAE Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 292: UAE 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 293: UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 294: UAE Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 295: UAE 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 296: UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 297: UAE Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 298: UAE 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 300: Rest of Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 301: Rest of Middle East 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 303: Rest of Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 304: Rest of Middle East 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 306: Rest of Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 307: Rest of Middle East 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
AFRICA
Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 308: Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 309: Africa Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 310: Africa 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2024 & 2030
TABLE 311: Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 312: Africa Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 313: Africa 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 314: Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 315: Africa Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 316: Africa 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings